WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Santiago Espinal has 3 RBIs, Fernando Cruz pitches out of another jam and Reds beat Phillies 7How do private enterprises tackle challenges with innovation?How a pheromone perfume could make you irresistible to the opposite sexSouth Carolina Senate approves $15.4B budget after debate on bathrooms and conference switchingImelda Staunton reveals The Crown's final episode had to be reAuthorities confirm 2nd victim of exDefending champion Golden Knights beat Stars 3China calls for strengthened flood control in Yangtze, Taihu Lake basinsUN report says 282 million people faced acute hunger in 2023, with the worst famine in GazaBlinken, in Shanghai, begins expected contentious talks with Chinese officials
2.8587s , 6500.125 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Stellar Stream news portal